A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence
Clinical diagnostics for SARS-CoV-2 infection usually comprises the sampling of throat or nasopharyngeal swabs that are invasive and create patient discomfort. Hence, saliva is attempted as a sample of choice for the management of COVID-19 outbreaks that cripples the global healthcare system. Althou...
Saved in:
Published in | Journal of photochemistry and photobiology. B, Biology Vol. 234; p. 112545 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Elsevier B.V
01.09.2022
Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Clinical diagnostics for SARS-CoV-2 infection usually comprises the sampling of throat or nasopharyngeal swabs that are invasive and create patient discomfort. Hence, saliva is attempted as a sample of choice for the management of COVID-19 outbreaks that cripples the global healthcare system. Although limited by the risk of eliciting false-negative and positive results, tedious test procedures, requirement of specialized laboratories, and expensive reagents, nucleic acid-based tests remain the gold standard for COVID-19 diagnostics. However, genetic diversity of the virus due to rapid mutations limits the efficiency of nucleic acid-based tests. Herein, we have demonstrated the simplest screening modality based on label-free surface enhanced Raman scattering (LF-SERS) for scrutinizing the SARS-CoV-2-mediated molecular-level changes of the saliva samples among healthy, COVID-19 infected and COVID-19 recovered subjects. Moreover, our LF-SERS technique enabled to differentiate the three classes of corona virus spike protein derived from SARS-CoV-2, SARS-CoV and MERS-CoV. Raman spectral data was further decoded, segregated and effectively managed with the aid of machine learning algorithms. The classification models built upon biochemical signature-based discrimination method of the COVID-19 condition from the patient saliva ensured high accuracy, specificity, and sensitivity. The trained support vector machine (SVM) classifier achieved a prediction accuracy of 95% and F1-score of 94.73%, and 95.28% for healthy and COVID-19 infected patients respectively. The current approach not only differentiate SARS-CoV-2 infection with healthy controls but also predicted a distinct fingerprint for different stages of patient recovery. Employing portable hand-held Raman spectrophotometer as the instrument and saliva as the sample of choice will guarantee a rapid and non-invasive diagnostic strategy to warrant or assure patient comfort and large-scale population screening for SARS-CoV-2 infection and monitoring the recovery process.
Label free detection of healthy, COVID-19 and recovered saliva using SERS guided Raman fingerprinting. [Display omitted]
•Label-free SERS technique has been developed for the discrimination of healthy and COVID-19 infected subjects using saliva•A proof-of-concept model study with saliva spiked different types of corona virus spike proteins was performed•The trained support vector machine classifier achieved a prediction accuracy of 95% for COVID-19 diagnosis•Illustrated a database for different stages of patient recovery with varying Raman signatures.•Higher prediction accuracy could be due to this small sample size employed |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Both authors are having equal contribution. Present Addresses: CSIR-National Institute for Interdisciplinary Science & Technology (NIIST), Chemical Sciences &Technology Division (CSTD), Industrial Estate, Thiruvananthapuram 695019, Kerala, India. |
ISSN: | 1011-1344 1873-2682 |
DOI: | 10.1016/j.jphotobiol.2022.112545 |